Mutation of Cys135, Cys176, and Cys275 significantly blocked nuclear translocation of TP53 and the expression of TP53 downstream targets, e.g., P21 and BAX, resulting in the promotion of tumor growth. This evidence concerns the gene TP53 and neoplasm.